Skip to content

The Prevention and Reactivation Care Programme: a personalized, integrated intervention for prevention of functional decline after hospital stay.

The Prevention and Reactivation Care Programme: a personalized, integrated intervention for prevention of functional decline after hospital stay. - ZPH study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36510
Enrollment
2900
Registered
2011-07-05
Start date
2011-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ouderen Geneeskunde: Multimorbiditeit Frailty Independence Multimorbidity

Interventions

Participants will receive care that is the standard at their hospital. In the Vlietland hospital this standard is the prevention and reactivation care program (ZPH). ZPH has been developed over many

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 65 years and older Admitted in one of the participating hospitals (expected stay >= 2 days) At risk for loss of function (score > 2 on the ISAR and score 15 or lower on the Barthel index and/or score 3 or higher on the NPI);Inclusion criteria for stay in the CPH: positive score on a functional assessment list. Including delirium score, clinical determinants such as anemia and low BMI, and the burden for the informal carer

Exclusion criteria

Exclusion criteria: Unable to answer questions or follow instructions (e.g. due to severe cognitive problems (MMSE score

Design outcomes

Primary

MeasureTime frame
The effect evaluation will assess patient and caregiver outcomes (e.g. health related quality of life, physical functioning, cognitive functioning, social and emotional functioning, psychological functioning, objective and subjective burden of care), duration of hospital stay as well as (re-)admittance in hospital or nursing homes and mortality. Costs will be determined from a societal viewpoint for evaluation of cost effectiveness of the ZPH compared to current, usual care

Secondary

MeasureTime frame
Secundary study parameters for the effect evaluation are cognitive functioning and psychological/social functioning of the patient and patient self management.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)